$AKBA Now we know it is due to FDA CRL. Still believe they are trying to get better terms.
otsuka.co.jp/en/company/new...
Announcement of Termination of Global License Agreements for Renal Anemia Treatment with Akebia Therapeutics, Inc.｜News Releases | Otsuka Pharmaceutical Co., Ltd.
via: Otsuka Pharmaceutical Co., Ltd.1
4